223 related articles for article (PubMed ID: 17184223)
1. Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine.
Cassone A; Torosantucci A
Expert Rev Vaccines; 2006 Dec; 5(6):859-67. PubMed ID: 17184223
[TBL] [Abstract][Full Text] [Related]
2. Prospects for development of vaccines against fungal diseases.
Dan JM; Levitz SM
Drug Resist Updat; 2006 Jun; 9(3):105-10. PubMed ID: 16820318
[TBL] [Abstract][Full Text] [Related]
3. Polysaccharide-containing conjugate vaccines for fungal diseases.
Casadevall A; Pirofski LA
Trends Mol Med; 2006 Jan; 12(1):6-9. PubMed ID: 16309965
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-based vaccination against opportunistic fungi.
Bozza S; Montagnoli C; Gaziano R; Rossi G; Nkwanyuo G; Bellocchio S; Romani L
Vaccine; 2004 Feb; 22(7):857-64. PubMed ID: 15040938
[TBL] [Abstract][Full Text] [Related]
5. Systemic fungal infections: major problems in cancer patients.
Powles RL; Mehta J
Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against fungal infections.
Segal E
Crit Rev Microbiol; 1987; 14(3):229-71. PubMed ID: 3556019
[TBL] [Abstract][Full Text] [Related]
7. [Fungal infections in patients with ARC with or without AIDS. Evaluation of the chemosensitivity of the isolated strains].
Michelone G; Cavanna C; Gramegna G; Maccabruni A; Lombardi G
G Ital Chemioter; 1987; 34(1-3):23-7. PubMed ID: 3504411
[No Abstract] [Full Text] [Related]
8. Preventative and therapeutic vaccines for fungal infections: from concept to implementation.
Deepe GS
Expert Rev Vaccines; 2004 Dec; 3(6):701-9. PubMed ID: 15606355
[TBL] [Abstract][Full Text] [Related]
9. Non-culture-based diagnostics for opportunistic fungi.
Mennink-Kersten MA; Verweij PE
Infect Dis Clin North Am; 2006 Sep; 20(3):711-27, viii. PubMed ID: 16984877
[TBL] [Abstract][Full Text] [Related]
10. [Is it possible to prevent mycotic infections in oncology patients?].
Mayer J; Vorlícek J
Vnitr Lek; 1994 Dec; 40(12):783-8. PubMed ID: 7839633
[TBL] [Abstract][Full Text] [Related]
11. Incidence of endogenous and exogenous opportunistic fungal infections in relation to different prophylactic measures: clinical and microbiological study of 431 immunocompromised patients.
Mazzoni A; Fiacchini M; Cevenini R; Gatti M; Nanetti A
Chemioterapia; 1987 Oct; 6(5):374-6. PubMed ID: 3427697
[TBL] [Abstract][Full Text] [Related]
12. Antifungal combinations.
Vitale RG; Afeltra J; Dannaoui E
Methods Mol Med; 2005; 118():143-52. PubMed ID: 15888940
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
14. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi.
Guarro J
J Antimicrob Chemother; 2011 Jul; 66(7):1447-66. PubMed ID: 21493649
[TBL] [Abstract][Full Text] [Related]
15. Fungal vaccines: real progress from real challenges.
Cassone A
Lancet Infect Dis; 2008 Feb; 8(2):114-24. PubMed ID: 18222162
[TBL] [Abstract][Full Text] [Related]
16. Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.
Hamad M
Scand J Immunol; 2008 Jun; 67(6):533-43. PubMed ID: 18397201
[TBL] [Abstract][Full Text] [Related]
17. [Current status of antifungal prophylaxis in opportunistic mycoses].
Torres-Rodríguez JM
Enferm Infecc Microbiol Clin; 1996 Jan; 14(1):44-53. PubMed ID: 8714187
[No Abstract] [Full Text] [Related]
18. Fungal vaccines, mechanism of actions and immunology: A comprehensive review.
Nami S; Mohammadi R; Vakili M; Khezripour K; Mirzaei H; Morovati H
Biomed Pharmacother; 2019 Jan; 109():333-344. PubMed ID: 30399567
[TBL] [Abstract][Full Text] [Related]
19. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
Steinbach WJ; Reedy JL; Cramer RA; Perfect JR; Heitman J
Nat Rev Microbiol; 2007 Jun; 5(6):418-30. PubMed ID: 17505522
[TBL] [Abstract][Full Text] [Related]
20. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
Prentice AG; Glasmacher A; Djulbegovic B
Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
